Literature DB >> 14588098

Peroxisome proliferator-activated receptor-gamma gene expression in orbital adipose/connective tissues is increased during the active stage of Graves' ophthalmopathy.

Lídia Y Mimura1, Sandra M F Villares, Mário L R Monteiro, Isabel C Guazzelli, Walter Bloise.   

Abstract

The mechanisms involved in the increase of orbital retro-ocular adipose tissue that occurs in Graves' ophthalmopathy (GO) are still unclear. In this condition, the orbital tissue shows glycosaminoglycans deposition produced by activated fibroblasts capable of undergoing adipocytic differentiation. Many genes are involved in adipogenic mechanisms including the transcription factor peroxisome proliferator-activated receptor-gamma (PPAR-gamma). We evaluated the level of expression of the PPAR-gamma gene in normal and GO orbital adipose/connective tissue specimens using a quantitative and sensitive reverse transcription (RT) competitive polymerase chain reaction (PCR) assay. Our results show that the expression of PPAR-gamma was significantly greater in adipose/connective tissue from patients in the active stage of GO than in controls (150.8 +/- 103.9 and 24.0 +/- 4.9 amol/micro g of total RNA respectively, p < 0.05), while there was no significant difference between patients with inactive GO (58.8 +/- 40.6 aM/microg total RNA) and controls. These results suggest that increased PPAR-gamma gene expression in the active stage of GO may be dependent on the inflammatory process in this disease. We speculate that the increased orbital fat tissue observed in GO may be a consequence of the anti-inflammatory PPAR-gamma action.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14588098     DOI: 10.1089/105072503322401032

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  14 in total

1.  Immunotherapy for Graves' orbitopathy: easy enthusiasm, but let's keep trying.

Authors:  L Bartalena; M L Tanda
Journal:  J Endocrinol Invest       Date:  2006-12       Impact factor: 4.256

Review 2.  Thyroid Dysfunction and Diabetes Mellitus: Two Closely Associated Disorders.

Authors:  Bernadette Biondi; George J Kahaly; R Paul Robertson
Journal:  Endocr Rev       Date:  2019-06-01       Impact factor: 19.871

3.  PPARg2 Ala¹² variant protects against Graves' orbitopathy and modulates the course of the disease.

Authors:  Edyta Pawlak-Adamska; Jacek Daroszewski; Marek Bolanowski; Jolanta Oficjalska; Przemyslaw Janusz; Marek Szalinski; Irena Frydecka
Journal:  Immunogenetics       Date:  2013-04-21       Impact factor: 2.846

4.  Orbital fibroblasts from thyroid eye disease patients differ in proliferative and adipogenic responses depending on disease subtype.

Authors:  Ajay E Kuriyan; Collynn F Woeller; Charles W O'Loughlin; Richard P Phipps; Steven E Feldon
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-11-08       Impact factor: 4.799

5.  Upregulation of the PPAR signaling pathway and accumulation of lipids are related to the morphological and structural transformation of the dragon-eye goldfish eye.

Authors:  Peng Yu; Yang Wang; Wen-Tao Yang; Zhi Li; Xiao-Juan Zhang; Li Zhou; Jian-Fang Gui
Journal:  Sci China Life Sci       Date:  2021-01-05       Impact factor: 6.038

Review 6.  Role of Peroxisome Proliferator-Activated Receptor γ in Ocular Diseases.

Authors:  Su Zhang; Hongwei Gu; Nan Hu
Journal:  J Ophthalmol       Date:  2015-06-04       Impact factor: 1.909

Review 7.  Peroxisome Proliferator-Activated Receptor- γ in Thyroid Autoimmunity.

Authors:  Silvia Martina Ferrari; Poupak Fallahi; Roberto Vita; Alessandro Antonelli; Salvatore Benvenga
Journal:  PPAR Res       Date:  2015-02-01       Impact factor: 4.964

Review 8.  The roles of PPARγ and its agonists in autoimmune diseases: A comprehensive review.

Authors:  Yu Liu; Jiayu Wang; Shuangyan Luo; Yi Zhan; Qianjin Lu
Journal:  J Autoimmun       Date:  2020-07-01       Impact factor: 7.094

9.  Thiazolidinedione induced thyroid associated orbitopathy.

Authors:  Seongmu Lee; Angelo Tsirbas; Robert A Goldberg; John D McCann
Journal:  BMC Ophthalmol       Date:  2007-04-26       Impact factor: 2.209

10.  Regulation of Lymphocyte Function by PPARgamma: Relevance to Thyroid Eye Disease-Related Inflammation.

Authors:  G M Lehmann; T M Garcia-Bates; T J Smith; S E Feldon; R P Phipps
Journal:  PPAR Res       Date:  2008       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.